合伙人
在化学科学领域多年的博士学术研究和行业研究,让封丽博士对创新过程有着切实的理解和认识,她将这些理解和认识运用于她工作中的广泛的技术领域,其中包括制药、生物科技、医疗设备、化学化工、农业、纳米技术、化妆品和冶金。
封丽律师的业务涉及:美国地区法院的专利诉讼、美国专利和商标事务局(USPTO)的专利审判及上诉委员会(PTAB)的授权后程序、专利申办、提供法律意见书和咨询,以及尽职调查等。她在制药、生物制剂、生物科技、医疗设备、化学化工、农业、纳米技术、化妆品和冶金等领域有丰富的技术经验。
封丽博士曾代表许多制药公司对简明新药申请(ANDA)进行诉讼 和处理诉前工作。 她负责管理一个非常大的医药专利组合,其覆盖多种候选临床药物,并曾成功代表许多公司在生物医药,生物科技以及电子产品领域处理专利审判及上诉委员会(PTAB)的程序。她还经常进行以知识产权为主题的演讲。
在从事法律工作前,封律师参与过大量的学术和工业研究,在包括药物开发、药物分析和配方、抗体、实验方法开发、医药化学、蛋白质化学、分子生物学、和基于计算机的分子模型的广泛领域中获得了大量而丰富的专业知识和实践经验。
2008年曾任犹他州最高法院首席法官Matthew B. Durrant的实习生。
2015年担任法律多样性领导委员会会员。
Represented the patent owner in an inter partes review before the PTAB and obtained a favorable ruling.
IPR2020-00503, PTAB, Judges Abraham, Guest, Heaney
Represented Biogen in a Hatch-Waxman litigation involving twenty-eight companies seeking FDA approval to market generic versions of Tecfidera®.
1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley
Represented Biogen in an inter partes review before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
IPR2018-01403, PTAB, Judges Chagnon, Harlow, Snedden
Represented Biogen in an inter partes review before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
IPR2015-01086, -01136, -01993, PTAB, Judges Gardener-Lane, Katz, Schafer
Represented agro-chemical companies at the International Trade Commission and obtained a favorable ruling.
337-TA-914, ITC, Judge Lord
Represented Biogen in an interference proceeding before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
106,023, PTAB, Judges Gardner-Lane, Katz, Schafer
Represented Sequenom, Inc. et al in three interference cases before the PTAB of the USPTO and obtained favorable rulings relating to Dr. Dennis Lo’s inventions on noninvasive prenatal diagnosis.
105,920; 105,923; 105,924, PTAB, Judges Gardner-Lane, Katz, Moore
Represented LG (Lee) in a patent interference provoked by competitor Whirlpool (Voglewede) attempting to challenge LG refrigerator patents; judgment entered against Whirlpool and in favor of client LG.
Int. No. 105711, Board of Patent Appeals and Interferences, Judge Lee
Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al.
Represented the patent owner in an inter partes review before the PTAB and obtained a favorable ruling.
IPR2020-00503, PTAB, Judges Abraham, Guest, Heaney
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Represented Biogen in a Hatch-Waxman litigation involving twenty-eight companies seeking FDA approval to market generic versions of Tecfidera®.
1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Represented Biogen in an inter partes review before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
IPR2018-01403, PTAB, Judges Chagnon, Harlow, Snedden
Coalition for Affordable Drugs V LLC v. Biogen MA Inc.
Represented Biogen in an inter partes review before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
IPR2015-01086, -01136, -01993, PTAB, Judges Gardener-Lane, Katz, Schafer
Certain Sulfentrazone, Sulfentrazone Compositions, and Processes for Making Sulfentrazone
Represented agro-chemical companies at the International Trade Commission and obtained a favorable ruling.
337-TA-914, ITC, Judge Lord
Forward Pharma IP APS v. Biogen MA, Inc.
Represented Biogen in an interference proceeding before the PTAB and obtained a favorable ruling for a patent covering Tecfidera®.
106,023, PTAB, Judges Gardner-Lane, Katz, Schafer
Event
3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 10-26, 2023
Virtual
Event
Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 11-27, 2022
Webinar
Event
Frameworks for US Pharma Patent Disputes Frameworks for US Pharma Patent Disputes
June 30, 2022
Webinar
Articles
China’s “Hatch-Waxman” System: A Comparative Overview China’s “Hatch-Waxman” System: A Comparative Overview
September 8, 2021
WestlawAnnouncement
Finnegan Announces 2023 Mentors of the Year Finnegan Announces 2023 Mentors of the Year
December 29, 2023
Commentary
China's Patent Linkage System Is Finally Up and Running China's Patent Linkage System Is Finally Up and Running
July 15, 2021
Intellectual Asset ManagementPress Release
Finnegan Ranks in the Top 15 as a 2017 Working Mother "Best Law Firm for Women" Finnegan Ranks in the Top 15 as a 2017 Working Mother "Best Law Firm for Women"
July 25, 2017
Working MotherPress Release
Finnegan Announces Eleven New Partners Finnegan Announces Eleven New Partners
January 3, 2017
University of Utah
J.D., with high honors, 2008
Ph.D., Medicinal Chemistry, 1999
Peking University
M.S., Physical Chemistry, 1993
B.S., Chemistry, 1990
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.